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a b s t r a c tAim: The Lifetime Impairment Survey assessed how ADHD impairs everyday life, identifying areasmost affected.
Methods: This opinion-based survey evaluated experiences, diagnosis and treatment of lifetime impairment in
adults with (n = 89) and without (n = 94) ADHD. Groups were compared using impairment and symptoms
scales; higher scores indicate greater impairment.
Results: Mean (standard deviation) age at diagnosis was 18.2 (11.5) years; 47.1% were taking prescription
medication for ADHD. Adults with ADHD reported greater impairments than those without for all scales
(p b 0.001) except the involvement scale.
Conclusion:Greater impairments in adults with thanwithout ADHD suggest a continued impact throughout their
daily lives.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).BACKGROUND
Attention-deﬁcit/hyperactivity disorder (ADHD) has a worldwide
prevalence of 5% in children (Faraone, Sergeant, Gillberg, & Biederman,
2003; Polanczyk, de Lima, Horta, Biederman, & Rohde, 2007). In the UK,
a survey conducted in 1999 of approximately 10,500 children between
5 and 15 years of age, 3.6% of boys and 0.9% of girls were diagnosedwith
ADHD (Ford, Goodman, & Meltzer, 2003). Outcome studies ﬁnd that
ADHD symptoms and impairments persist into adulthood in around
65% of cases (Faraone, Biederman, & Mick, 2006) and a more balanced
prevalence of the disorder is generally observed between the sexes
(Bernardi et al., 2012; Kessler et al., 2005b; Simon, Czobor, Balint,
Meszaros, & Bitter, 2009). The impact of ADHD on everyday life may
diminish with age, with many patients developing effective coping
mechanisms; nevertheless, ADHD often remains an impairing condition
in adults (Asherson et al., 2012; Primich & Iennaco, 2012).
ADHD-related impairments such as poor time management,
procrastination and distractibility can affect areas of life, including
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creased accidents, medical resource utilization, antisocial behavior,
drug and alcohol abuse and dependency (Asherson et al., 2012). A
large national survey in the USA of more than 34,000 adults 18 years
and older found that a lifetime history of ADHD was associated with an
increased risk of behaviors reﬂecting a lack of planning and poor self-
regulation of behavior,with higher perceived stress levels and lower per-
ceivedhealth and social support (Bernardi et al., 2012). A study exploring
the burden of illness and impact on QoL in older adults with ADHD
(mean 66 years) concluded that QoL suffered from the accumulative
negative impact of ADHD impairments on many aspects of daily life
and well-being (Brod, Schmitt, Goodwin, Hodgkins, & Niebler, 2012).
Long-term prospective ﬁndings from a 16-year follow-up study pro-
vide evidence for the high morbidity associated with ADHD across the
life cycle that could not be accounted for by other mental health condi-
tions (Biederman et al., 2012). This study found relatively low rates of
co-occurring conditions, perhaps resulting from the early diagnosis
and treatment of the patient group. In contrast, cross-sectional studies
of ADHD ﬁnd a high frequency of other diagnoses and co-occurring
symptom groups that make important additional contributions to im-
pairment (Kessler et al., 2006; Kooij et al., 2010; Skirrow, Hosang,
Farmer, & Asherson, 2012). Approximately 70% of adult patients with
ADHD have at least one comorbid disorder (Garcia et al., 2012). These
patients have an increased risk of emotional lability, generalized anxiety
disorder, post-traumatic stress disorder, speciﬁc phobias and personality
disorders that contribute to signiﬁcantly lower psychological health
scores (Bernardi et al., 2012; O'Callaghan & Sharma, 2012).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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concern because sufﬁcient training of mental health professionals and
provision of services have been slow to develop. As a consequence,
adults with ADHD continue to go unrecognized or misdiagnosed, with
treatments targeted at secondary consequences of ADHD rather than
the primary condition. This is a particular concern as the effectiveness
of available medical and psychological treatments has been well
demonstrated (Kooij et al., 2010; National Institute of Health & Care
Excellence, 2009; Nutt et al., 2007).
One important aspect to understanding ADHD in adults is to
delineate the types of impairments experienced in daily life. Here we
report the ﬁndings of the Lifetime Impairment Survey (LIS), a survey
of adults with ADHD living in the UK, about current impairments and
experiences of the diagnostic and treatment process.
The aim of the LIS was to assess the degree to which ADHD impairs
patients' everyday lives and identify the areas of life most affected by
the condition (Caci et al., 2011, 2013; Hervas et al., 2011). Based on a pre-
viously published US survey conducted in adultswith ADHD (Biederman
et al., 2006), this survey was conducted across six European countries
(France, Germany, Italy, the Netherlands, Spain and the UK). Data were
collected from parents and caregivers of children with ADHD and adults
with ADHD, and compared with corresponding children/adults without
ADHD. Herewe focus on the UK data alone from adults with ADHD com-
pared with those without the disorder.
METHODS
The LIS was a large, online opinion-based survey designed to
evaluate the extent of lifetime impairment in individuals with ADHD.
The responses obtained from adults with ADHD regarding their current
situation and experiences were compared with those obtained from
adults without ADHD. The full methodology has been published else-
where (Caci et al., 2013) and is described brieﬂy below.
Recruitment and Study Population
Adults were recruited by email invitation from GfK Global Online
Panel (GfK Healthcare, London) using their independent consumer da-
tabase of 487,533 volunteer members (130,203 in the UK) who had
agreed to participate in market research. Panel members are continu-
ously enrolled using a variety of recruitment techniques, e.g. Website
advertisements and search engines. Adults enrolled were informed
about their rights and responsibilities, and completed a demographic
proﬁling survey. Separate consent is not obtained for each survey adults
participate in; however, survey participation is voluntary and panellists
may exit a survey at any time. To maintain conﬁdentiality, individuals
were de-identiﬁed. In exchange for participation, adults were invited
to nominate a charity to which a donation would be made on their be-
half and had the opportunity to enter a prize draw.
Adults with and without ADHD were identiﬁed using information
collected during demographic proﬁling regarding whether they had
ever been diagnosedwith ADHD by a doctor or other healthcare profes-
sional. Final allocation to the ADHD groupwas based on the response to
a question in the survey onwhether a doctor or other healthcare profes-
sional had ever made a diagnosis of ADHD, attention deﬁcit disorder or
hyperkinetic disorder. A minimum number of 100 participants per
group in each country were obtained. This study was not powered to
allow formal comparisons between groups (with and without ADHD;
statistical testing was exploratory only) and no formal sample calcula-
tions were performed. All p-values reported are nominal, without cor-
rection for multiple comparisons.
Survey Design and Data Analysis
The survey was designed for the purpose of this study by a Steering
Committee of psychiatrists and psychologists specializing in ADHD(including Author 3 and representatives from the study sponsor
[Shire Development, LLC]) and was conducted in accordance with in-
dustry guidelines (British Healthcare Business Intelligence Association,
2012; European Pharmaceutical Market Research Association, 2012;
Market Research Society, 2012; World Association of Research
Professionals, 2012) by an independent market research organization
(GfKHealthcare, London). Ethics committee approvalswere not required.
Adults with and without ADHD answered questions regarding their
current and past experiences, organized into four sections: screening
and classiﬁcation (e.g. demographics and health); impairment and gen-
eral well-being in childhood/adolescence; impairment in adulthood
(e.g. impact on work, social life and relationships); and ADHD diagnosis
and treatment.
Questions about impairment andwell-beingwere combined into 10
scales evaluating the level of difﬁculties currently encountered by par-
ticipants in different areas. Separate retrospective recall scales were
used to ascertain how adults remembered their previous school and
childhood/adolescent experiences. Items were grouped into scales by
the Steering Committee based on face-validity and expert consensus.
As necessary, scaleswere reversed so that higher scores indicated great-
er impairment (e.g. the work impairment scale).
Adults who gave impossible/implausible answers (e.g. a time to di-
agnosis greater than age) were excluded from the analysis. Adults
with and without ADHD were compared using t-tests for continuous
data and chi-squared tests for categorical data. To create graphs, top-
two box comparisons (e.g. combining responses ‘strongly agree’ and
‘somewhat agree’) were used to show differences between groups for
some individual items within the scales. Mean impairment and symp-
toms scale scores were calculated for all adults who answered at least
half of the questions in a particular scale; only adults with scores on
all applicable scales were included in scale-related analyses.
RESULTS
Characteristics of Participants
A total of 210 adults (105with and 105 without ADHD) from the UK
responded to the survey. Exclusion of respondents who provided im-
plausible or impossible answers (16 with and 11 without ADHD;
12.9% overall) yielded a sample of 89 adults with ADHD (51.7% males)
and 94 adults without ADHD (43.6% males). Their demographics and
background characteristics are shown in Table 1.
Adults with ADHDwere signiﬁcantly younger compared with adults
without ADHD (mean age [standard deviation (SD)] 32.1 [11.5] years vs.
45.6 [15.0] years, respectively; p b 0.001) at the time of completing the
survey and group differences were therefore adjusted using age as a co-
variate. Mean (SD) age at diagnosis was 18.2 (11.5) years.
Participants with ADHD tended to live in urban or suburban areas
(91.9%), whereas those without ADHD were more likely to live in
rural areas (25.6%; p b 0.01). Additionally, participants with ADHD
were more likely to have children (53.9%, 1–4 per family) than those
without ADHD (4.4%; p b 0.001). A signiﬁcantly higher percentage of
adults with ADHD earned ≥£50,000 than those without (29.6% vs.
10.8%; p b 0.05) and 11.1% earned ≥£80,000 (compared with only
1.2% in those without ADHD); 10.6% adults without ADHDwere retired
compared with none of the adults with ADHD (Table 1).
Table 2 shows the reported psychiatric diagnoses. The majority of
respondents without ADHD also had no other psychiatric diagnosis
(69.1%). Adults with ADHD reported a mean (SD) of 3.2 (3.5) comor-
bid conditions (median 2.0). The most frequently reported comor-
bidities by adults with ADHD were: depression (60.7% vs. 19.1%
adults without ADHD); insomnia or other sleep disorders (46.1%
vs. 7.4% adults without ADHD) and anxiety disorder(s) (40.4% vs.
5.3% adults without ADHD). The number of comorbidities did not
differ between adults with ADHD diagnosed before or after
18 years of age (p = 0.674).
Table 1
Demographic Characteristics of Respondents With and Without ADHD.
Characteristic
Adults with
ADHD (n = 89)
Adults without
ADHD (n = 94)
Mean (SD) age, years⁎⁎⁎ 32.1 (11.5) 45.6 (15.0)
Sex
Male 46 (51.7) 41 (43.6)
Current relationship status [89/91]
Single, without steady partner 36 (40.4) 31 (34.1)
Married 29 (32.6) 36 (39.6)
Living with steady partner,
but not married
16 (18.0) 15 (16.5)
Have a steady partner but
not living with him/her
8 (9.0) 9 (9.9)
Number of children⁎⁎⁎ [89/92]
None 41 (46.1) 88 (95.7)
One 18 (20.2) 2 (2.2)
Two 17 (19.1) 1 (1.1)
Three 10 (11.2) 1 (1.1)
Four 3 (3.4) N/A
Education level [88/93]
Low 3 (3.4) 1 (1.1)
Medium 26 (29.5) 37 (39.8)
High 59 (67.0) 55 (59.1)
Employment status
Employed full-time 52 (58.4) 44 (46.8)
Employed part-time 13 (14.6) 13 (13.8)
Student 5 (5.6) 3 (3.2)
Retired 0 10 (10.6)
Unemployed 12 (13.5) 14 (14.9)
Homemaker 3 (3.4) 4 (4.3)
Other 4 (4.5) 6 (6.4)
Household income (GB£)⁎ [81/83]
b20,000 22 (27.2) 32 (38.6)
20,000–49,999 35 (43.2) 42 (50.6)
50,000–79,999 15 (18.5) 8 (9.6)
80,000 or more 9 (11.1) 1 (1.2)
Community type⁎⁎ [87/90]
Urban (within a city) 39 (44.8) 25 (27.8)
Suburban
(in the suburbs of a city or in a town)
41 (47.1) 42 (46.7)
Rural (in the country) 7 (8.0) 23 (25.6)
Mean (SD) personal income,
1000 Eurosa [66/64]
28.9 (25.6) 21.5 (16.8)
NOTE. Data are given as n (%) unless indicated otherwise. Numbers in square brackets show
numbers of adults with ADHD/adults without ADHDwhen different to the numbers given
in the columns per group.
ADHD, attention-deﬁcit/hyperactivity disorder; N/A, not applicable; SD, standard
deviation.
a Personal incomes were normalized and individuals with income N2.5 SD above the
mean were set to missing (p = 0.051).
⁎ p b 0.05, Student's t-test.
⁎⁎ p b 0.01, Student's t-test.
⁎⁎⁎ p b 0.001, Student's t-test.
Table 2
Comorbidities and Pathologies of Respondents With and Without ADHD.
Condition n (%)
Adults with
ADHD (n = 89)
Adults without
ADHD (n = 94)
Depression 54 (60.7) 18 (19.1)
Insomnia or other sleep disorders 41 (46.1) 7 (7.4)
Anxiety disorder(s) 36 (40.4) 5 (5.3)
Personality disorder 27 (30.3) 1 (1.1)
Bipolar disorder 20 (22.5) 1 (1.1)
Alcohol or drug abuse or dependence 19 (21.3) 6 (6.4)
Oppositional deﬁant disorder 15 (16.9) 0
Conduct disorder 15 (16.9) 0
Decline to answer 0 4 (4.3)
None of these 0 65 (69.1)
NOTE. ADHD, attention-deﬁcit/hyperactivity disorder.
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For adults with ADHD, the mean (SD) age at diagnosis was 18.2
(11.5) years; 44.9% of respondents were aged ≥18 years when ADHD
diagnosis was received. Approximately one ﬁfth (21.3%) of adults with
ADHDwere diagnosed between the ages of 6 and 10 years and approx-
imately one quarter (23.6%) were diagnosed when aged between 11
and 17 years. Adults with ADHD diagnosed before 18 years of age did
not differ signiﬁcantly on any of the scales from those diagnosed as
adults. The majority of respondents recalled having to wait for over a
year (69.6%) and saw at least three doctors (51.7%) to receive a diagno-
sis. Patients visited amean (SD) of 3.3 (3.4) physicians (median 3.0) and
diagnosis of ADHD was obtained after a mean (SD) duration of 49.4
(88.2) months (median: 14.0 months, n= 56). Over one third (39.3%)
reported frustration at the number of visits to the doctor before they
received a diagnosis and one ﬁfth (20.2%) reported experiencing no dif-
ﬁculties or frustrations. Also, approximately one third (30.3%) reported
that their doctor was sceptical about ADHD as a diagnosis in adults,
viewing it as a paediatric condition.
When asked to specify how they were being treated or what help
they were receiving for their ADHD, only 25.8% of participants con-
ﬁrmed they were taking prescription medication, either alone (11.2%)
or in combination with behavioral interventions (14.6%); 37.1% were
receiving behavioral interventions only. Some form of therapy was the
most common non-pharmacological intervention received by adults
with ADHD (21.3%).
Themost commonly prescribed ADHDmedicationswere immediate-
release stimulants (27.0%) followed by long-acting preparations (16.9%)
and atomoxetine (5.6%). The majority of respondents (66.7%) declared
being satisﬁed with their medication, while 20.5% were dissatisﬁed
with their current treatment; 12.8% were neither satisﬁed nor dissatis-
ﬁed. When questioned on the improvements they would like to see in
their medication, respondents reported that it was very or quite impor-
tant for: the efﬁcacy of their medication to be improved (82.5%), to
have fewer adverse events or side effects (74.4%), to have a swift onset
of action (75.0%), for the medication to work throughout the day and
into the evening (82.5%), to have a lower frequency of dosing (70.0%)
and to have a smooth delivery proﬁle (64.1%).ADHD Impairment and Symptoms Scale Scores
The mean scores obtained by adults with and without ADHD in the
impairment and symptom scales are presented in Table 3. Adults with
ADHD reported signiﬁcantly greater impairments than adults without
ADHD in all scales (p b 0.001) except the involvement scale (i.e. inclina-
tion to spend time with friends/family and participate in different types
of activities), for which the two groups obtained similar mean scores
(2.0 and 2.1, respectively). When examining the inﬂuence of age, a sig-
niﬁcant age effect was observed in three scales: self-organization
(p b 0.001), involvement (p = 0.003) and mood/temper (p = 0.013).
While a signiﬁcant effect of age was observed on these scales, they
remained signiﬁcantwhen agewas controlled. However, when control-
ling for age, there was no longer a signiﬁcant difference between adults
with and without ADHD in the involvement scale (p= 0.822).
The areas associated with signiﬁcantly greater difﬁculties in
the ADHD group included social functioning (p b 0.001), partnership re-
lationships (p b 0.001), personal ﬁnances (p b 0.001), mood/temper
control (p b 0.001), self-organization and planning (p b 0.001) and
rule-breaking behavior (p b 0.001). Adults with ADHD reported greater
work difﬁculties (p b 0.001) and a greater number of jobs in the
past 10 years (p b 0.001) compared with those without ADHD
(mean [SD] number 4.4 [2.8] vs. 2.3 [1.8], respectively). The responses
of participants in relation to the individual items comprising the social,
partnership, work and ﬁnancial impairment scales are shown in
Figs. 1–4, respectively.
Table 3
ADHD Impairment and Symptom Scale Scores.
Scale/score Number of items per scale
Mean (SD) score
Adults with ADHD (n = 89) Adults without ADHD (n = 94)
Mood/temper control scale⁎ 5 3.2 (0.8) 2.4 (0.8)
Work impairment scale⁎ 15 3.0 (0.5)
a 2.4 (0.6)b
Self-organization and planning scale⁎ 10 3.2 (1.1) 1.8 (0.8)
Involvement scale 5 2.0 (0.5) 2.1 (0.5)
Social impairment scale⁎ 8 2.7 (0.8) 1.9 (0.7)
Partnership impairment scale⁎ 5 2.8 (0.7)
c 2.1 (0.8)d
Financial impairment scale⁎ 9 3.1 (1.1) 2.3 (1.0)
Rule-breaking behavior score⁎ 7 2.5 (2.0) 1.1 (1.5)
Perceived impact scale 8 3.2 (1.4) –
Perceived impairment scale 13 3.6 (0.8) –
NOTE. ADHD, attention-deﬁcit/hyperactivity disorder; SD, standard deviation.
a n = 65.
b n = 57.
c n = 53.
d n = 63.
⁎ p b 0.001 between groups; Student's t-test.
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life, particularly the negative impact on academic achievement (50.0%
adults with ADHD), daily life and activities (42.7%) and professional/
working life (40.2%). When recalling how ADHD affected life during
childhood and adolescence (gathered in separate retrospective recall
scales), data showed a signiﬁcant association with poor school perfor-
mance. Adults with versus those without ADHD recalled signiﬁcant
school impairment (p b 0.001), for example, whether they got along
with their teachers and whether they were popular in school; and
signiﬁcant school failure (p b 0.001), for example, whether they were
‘bottom’ of the class or got expelled or suspended. Adults with ADHD
did not report signiﬁcant differences compared with adults without
ADHD for impairments in relationships during childhood and adoles-
cence, for example, whether they got along with friends outside of
school andwhether theywere popular outside of school.When control-
ling for age, a signiﬁcant age effectwas observed in comorbid symptoms
(p = 0.004) and school failure (p = 0.007). When controlling for age,
there was no signiﬁcant difference between adults with and without0 20
When in social situations, I often make mistakes
or act in ways that others see as inappropriate
I have a good relationship with my parents
I fit in with my peers
I get into arguments or fights easily
I lose friends easily because of
my impulsive behaviour
I try to avoid social events because my
behaviour can be embarassing
I avoid certain situations because of
my impulsivity and mood instability
I don't enjoy shopping because
I don't like waiting in queues
19a
a
a
a
b
c
c
c
5.3
6.5
2
5.3
9.6
Fig. 1. Impairments in social functioning as indicated by the social impairment scale. an=93; bn=ADHD in the home impairment (p = 0.306) and relationship impair-
ment scales (p= 0.403).DISCUSSION
There were important limitations associated with this study and
these data should be considered in the context of these limitations. LIS
was not a validated questionnaire and, therefore, care should be taken
when interpreting the results. Adults who responded to the study invi-
tation represent a select, well-educated, IT-literate populationwilling to
participate in the survey; an awareness of ADHD and its associated
symptoms and impairmentsmay have been greater in this group of par-
ticipants compared with the general population. Adults without ADHD
were signiﬁcantly older than the adults with ADHD and included
more retired respondents. This age difference signiﬁcantly inﬂuenced
ﬁve of the impairment scales; when controlling for age no signiﬁcant
differences between groups were seen for three scales (home and40 60 80 100
ADHD group (n=89)
Non-ADHD group (n=94)
Respondents (%)
.4
46.1***
63.8
47.7*
54.8
40.9
27.3***
0.2**
24.7***
25.8
31.5
33.7***
80; cn=88. *pb 0.05; **pb 0.01; ***pb 0.001. ADHD, attention-deﬁcit/hyperactivity disorder.
0 20 40 60 80 100
ADHD group (n=53)
Non-ADHD group (n=63)
I am quick to lose my temper
with my partner or loved one
My relationship with my partner
or loved one is stable
I am easily distracted during sex, causing
frequent breaks or turn-offs during love-making
When he or she needs it, I am able to provide
the support my partner or loved one needs
I sometimes think my partner or loved one
would be better off without me
Respondents (%)
22.2
41.5*
80.6a
b
49.1**
24.6
39.2c
28.6
49.1*
81.0
64.2*
Fig. 2. Difﬁculties in partner relationships as shown by the partnership impairment scale (only includes participants with a current partner). an = 62; bn = 57; cn = 51. *p b 0.05;
**p b 0.001. ADHD, attention-deﬁcit/hyperactivity disorder.
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half of respondents were diagnosed above the age of 17 years, which
although it does not reﬂect current practice in the UK is similar to
the ﬁndings reported for adults with ADHD in Europe (20 years;
(Caci et al., 2014); however, age at diagnosis did not affect the level of
impairment indicated on the 10 scales.
Adults without ADHD were more likely to live in rural than urban
areas compared with adults with ADHD. It was unexpected that adults
with ADHD were, on average, higher earners than those adults without
ADHD, despite the presence of a greater level of self-reported social and
occupational difﬁculties, suggesting an atypically productive and high
functioninggroup of patientswithADHD, despite reported impairments0 2
I have trouble getting things done
unless there is an immediate deadline
I have a poor sense of time
I often argue with my co-workers and/or superiors
I am frequently angry or resentful at work
I often feel stressed or overwhelmed
by job-related responsibilities
I am touchy or easily annoyed by my co-workers
I am one of the first people my boss would consider
for a promotion if a better position became available
It is easy for me to concentrate on work
Unless they are very interesting to me, I am unable
to pay attention to things for long periods of time
I make careless mistakes at work
I sometimes have difficulty following instructions
a
a
a
a
14.0
8.9b
b
b
c
12.5
1
Fig. 3. Impairments in work functioning as indicated by the work impairment scale. an= 64; b
disorder.(Halmoy, Fasmer, Gillberg, & Haavik, 2009; Kessler et al., 2005a). This
could be related to greater access to healthcare facilities for higher
functioning individuals with ADHD. Other factors might be the cheaper
living costs in urban areas or reﬂect the older demographic of those
adults without ADHD. There are, therefore, uncertainties inherent in
the patient-reported data, including self-reported ADHD diagnosis.
Although some adults were excluded based on obvious implausible
answers, no control for other potential data entry errors could be applied.
• This study investigated the experiences of adultswith ADHD in the
UK using survey data from the European LIS study. Impairments
reported by adults with ADHD were all signiﬁcantly greater than0 40 60 80 100
ADHD group (n=65)
Non-ADHD group (n=57)
Respondents (%)
24.6
48.4**
55.4***
29.2**
26.8
26.3
46.9*
50.8**
31.6
56.9**
30.8
54.7**
50.8***
7.5
49.2***
35.1
57.8*
61.4*
43.1
n= 56; cn= 52. *p b 0.05; **p b 0.01; ***p b 0.001. ADHD, attention-deﬁcit/hyperactivity
0 20 40 60 80 100
ADHD group (n=89)
Non-ADHD group (n=94)
Difficulty saving for retirement
Having a poor credit rating
Exceeding credit card limit
Bouncing cheques
Being in debt
Difficulty managing personal finances
Missing important payments
(rent, utilities, bills)
Buying on impulse
Difficulty saving money
Respondents (%)
43.5a
b
b
d
f
b
a
a
e
d
c
d
51.8
36.1*
18.9
22.2
42.0**
6.7
32.9***
10.2
29.6***
10.8
33.0***
16.0
53.9***
34.0
53.9**
19.1
39.3**
Fig. 4. Financial difﬁculties as indicated by the ﬁnancial impairment scale. an=85; bn=90; cn=83; dn=88; en=81; fn=93. *p b 0.05; **p b 0.01; ***p b 0.001. ADHD, attention-deﬁcit/
hyperactivity disorder.
61M. Pitts et al. / Archives of Psychiatric Nursing 29 (2015) 56–63those without ADHD, with the exception of the home, relationship
impairment and involvement scale, suggesting the widespread
impact that ADHD has on QoL and many aspects of daily life.
These data are in agreement with previous literature reporting
the negative impact of ADHD in adulthood on relationships and
QoL (Agarwal, Goldenberg, Perry, & William, 2012; Asherson
et al., 2012; Bernardi et al., 2012; Brod et al., 2012) and is consis-
tent with the overall European adult sample across all six coun-
tries, in which all scales showed signiﬁcant impairment except
the involvement scale (Caci et al., 2013). Adults also recalled
their poor performances at school and, even though this may be0 20
Personal finances
Academic life
Social life
Professional/work life
Relationship with a spouse/partner
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Fig. 5. Perceived negative impact of ADHD on daily life as indicated by the perceived impact scale.
disorder.subject to memory bias, add compelling evidence that ADHD is a
life-long disorder.
The data show a broad range of co-occurring conditions associated
with ADHD in adults, with a distribution that is similar to that reported
in the literature (Biederman et al., 2012, 2012; Kessler et al., 2006, 2006;
Kooij et al., 2010). There was a particularly high prevalence for depres-
sion, sleep problems and anxiety in the adults with ADHD.
Almost half (45%) of the adults with ADHD were 18 years or older
when diagnosed with ADHD. Adult services should be mindful,
therefore, of the possibility of undiagnosed ADHD when assessing40 60 80 100
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62 M. Pitts et al. / Archives of Psychiatric Nursing 29 (2015) 56–63adult patients, particularly those with long-standing (chronic) mental
health problems. This is also complicated by the high frequency
of other diagnoses and comorbidities prevalent among adults with
ADHD (Kessler et al., 2006; Kooij et al., 2010; Skirrow et al., 2012) and
the high level of mental health symptoms that are seen to accompany
ADHD even in non-comorbid cases (Skirrow et al., 2012).
Themajority of adults recalled having to wait for over a year and see
at least three doctors to receive a diagnosis of ADHD. This difﬁculty,
particularly the length of time to diagnosis, may arise for a number of
different reasons. ADHD was formerly considered purely a childhood
disorder by national guidelines, and in the UK it has only recently
been formally recognized as a lifespan neurodevelopmental disorder
with a high persistence rate into adulthood (National Institute of Health
& Care Excellence, 2009). Difﬁculty in diagnosis may therefore be relat-
ed, at least in part, to a lack of awareness that the condition persists in
adults and consequently a reluctance of general practitioners and
other healthcare professionals to refer. Furthermore, training in the di-
agnosis and treatment of ADHD in adults has been lacking from most
adult mental health and primary care training programs. For example,
to date, there has been no systematic training of nurses, although nurses
are often the main point of contact for adults with mental health prob-
lems. Indeed, in this study, participants reported their frustration in the
diagnostic process, with some doctors being sceptical about the clinical
value of the adult diagnosis and its treatment. Hence there is a contin-
ued need for the training/education of all healthcare professionals and
an increase in the public awareness of ADHD in adulthood. Other impor-
tant contributing factors include lack of ADHD services for adults in
many regions of the UK, or treatment of other mental health conditions
prior to a diagnosis of ADHD being established.
• In adults with ADHD, prescription medication and behavioral in-
terventions were the two most common forms of treatment; a
third of adults received no treatment for ADHD. Reasons why
this might be the case were not collected in this survey and are
therefore open to speculation: for example, a reluctance to pre-
scribe medication, lack of services including access to psychologi-
cal treatments, patients not wishing to engage with treatment
programs, patients functioning at a level where they believe they
do not require treatment, or related to the way the survey was
conducted. In terms of medical treatments for ADHD, the majority
of patients receiving ADHD medications (67%) were satisﬁed, al-
though they did identify areas for improvement, including shorter
onset of action, longer duration of action and a lower frequency
of dose.
• Comparedwith adultswithout ADHD, the impairments reported by
adultswithADHD in theUK in the LIS suggest a continued impact of
the condition on both personal and professional life. These results
are in agreement with the data obtained for the overall European
sample and suggest that diagnostic practice across the European
countries included in the survey is comparable (Caci et al., 2013),
supporting the same point that was noted in the European consen-
sus statement on ADHD in adults (Kooij et al., 2010).
CONCLUSION
The greater impairments reported by adults with versus thosewith-
out ADHD in this UK survey suggest an impact of the condition on both
their personal and professional lives. It is important to emphasize that,
in the UK, adults with ADHD often have to wait for over a year and con-
sult several doctors before a diagnosis is made, due in part perhaps to a
lack of awareness of the disorder in adults. However, the similarity be-
tween the UK and European results suggest that ADHD can have a sig-
niﬁcant and lifelong impact on daily life, affecting adult patients
irrespective of the cultural differences between countries. There is a
continued need for training/educating healthcare professionals on
ADHD in adulthood, and improvements in service provision for adults.Acknowledgment
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